Loading…
Lobbying Spend
—
Filings
48
Firms Hired
1
Active Period
2015–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Biosimilar Red Tape Elimination Act
2026 · third_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: H.R.5526
Expedited Access to Biosimilars Act
2026 · third_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: H.R.9661
Expedited Access to Biosimilars Act
2026 · third_quarter · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: H.R.9661
Expedited Access to Biosimilars Act
2026 · third_quarter · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: S.1414
Expedited Access to Biosimilars Act
2026 · third_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: S.1414
Biosimilar Red Tape Elimination Act
2026 · third_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: S.1954
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2026 · third_quarter · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: S.2256
Biosimilar Red Tape Elimination Act
2026 · second_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Client expense: — · Firm income: $100,000
Matched citations: H.R.5526
Biosimilar Red Tape Elimination Act
2026 · second_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Client expense: — · Firm income: $100,000
Matched citations: S.1954
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2026 · second_quarter · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Client expense: — · Firm income: $100,000
Matched citations: S.2256
Biosimilar Red Tape Elimination Act
2026 · first_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Client expense: — · Firm income: $100,000
Matched citations: H.R.5526
Biosimilar Red Tape Elimination Act
2026 · first_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Client expense: — · Firm income: $100,000
Matched citations: S.1954
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2026 · first_quarter · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Client expense: — · Firm income: $100,000
Matched citations: S.2256
Biosimilar Red Tape Elimination Act
2025 · fourth_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Client expense: — · Firm income: $100,000
Matched citations: H.R.5526
Biosimilar Red Tape Elimination Act
2025 · fourth_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Client expense: — · Firm income: $100,000
Matched citations: S.1954
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · fourth_quarter · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Client expense: — · Firm income: $100,000
Matched citations: S.2256
Biosimilar Red Tape Elimination Act
2025 · third_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Client expense: — · Firm income: $100,000
Matched citations: H.R.5526
Biosimilar Red Tape Elimination Act
2025 · third_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act.
Client expense: — · Firm income: $100,000
Matched citations: S.1954
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · third_quarter · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Client expense: — · Firm income: $100,000
Matched citations: S.2256
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2025 · second_quarter · Firm: THORN RUN PARTNERS
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026.
Client expense: — · Firm income: $100,000
Matched citations: S.2256
Pharmacy Benefits Manager Accountability Act
2024 · fourth_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. H.R.2679 - Pharmacy Benefits Manager Accountability Act. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Client expense: — · Firm income: $100,000
Matched citations: H.R.2679
Biosimilar Red Tape Elimination Act
2024 · fourth_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. H.R.2679 - Pharmacy Benefits Manager Accountability Act. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Client expense: — · Firm income: $100,000
Matched citations: S.2305
Biologics Competition Act of 2023
2024 · third_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Client expense: — · Firm income: $100,000
Matched citations: H.R.1790
Pharmacy Benefits Manager Accountability Act
2024 · third_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Client expense: — · Firm income: $100,000
Matched citations: H.R.2679
Biosimilar Red Tape Elimination Act
2024 · third_quarter · Firm: THORN RUN PARTNERS
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Ensuring Access to Lower-Cost Medicines for Seniors Act. S.4302 - Senator Marshall, the Biologics Market Transparency Act. H.R.2679 - Pharmacy Benefits Manager Accountability Act. H.R.1790 - Biologics Competition Act of 2023. S.2305 - Biosimilar Red Tape Elimination Act. Inflation Reduction Act implementation.
Client expense: — · Firm income: $100,000
Matched citations: S.2305
Source: Senate LDA